EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury

Yifan Qing, Wenbo Zhao, Liangliang Xue, Yu Luo, Yuhao Gao, Xiang Sun, Fan Li, Linxuan Dai, Jing Mo, Guoqing Xu, Zenghao Bi iD, Suleixin Yang iD und 3 weitere

Cells · 2026

DOI: 10.3390/cells15030292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Yifan Qing und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Liposomes, Benzylisoquinolines, Receptors, CCR2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, China National Postdoctoral Program for Innovative Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe respiratory inflammation or viral infections can lead to acute lung injury (ALI), a disease characterized by diffuse inflammatory injury of the pulmonary epithelium and endothelium. Cepharanthine (CEP) is reported as a promising drug candidate due to its antiviral properties. However, CEP exhibits poor solubility and low bioavailability. Therefore, we developed a novel liposome, named CEP@LP-MCCR2, which integrates the advantages of cell membranes and lipid materials, to achieve effective accumulation of CEP in inflamed lungs. It exhibits a 1.73-fold increase in lung accumulation at 24 h in vivo, a 4.56-fold increase in cellular uptake in MLE-12 cells. CEP@LP-MCCR2 is equipped with a CCR2-overexpressed surface, enabling it to selectively neutralize elevated levels of CCL2, which is related to ALI, thereby reducing macrophage infiltration, thereby reducing the spread of inflammation, such as a reduction in levels of key pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). CEP@LP-MCCR2 could suppress M1 macrophage polarization, which led to a marked decrease in iNOS and an increase in Arg1. It upregulated the expression of junctional proteins E-cadherin and Occludin, indicating potential recovery of the pulmonary epithelial barrier. RNA sequencing analysis implied the potential of CEP@LP-MCCR2 to inactivate the TNF/NF-κB signaling axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryLiposomesBenzylisoquinolinesReceptors, CCR2Cell MembraneAnimalsBenzodioxolesMiceCell LineCytokinesMacrophagesLungMice, Inbred C57BL

Stichwörter der Autor:innen

acute lung injuryanti-inflammatorycepharanthineengineered CCR2 cell membraneliposomepotential targeted strategy

Substanzen

cepharanthineLiposomesBenzylisoquinolinesBenzodioxolesReceptors, CCR2Ccr2 protein, mouseCytokines

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • M. Kandiah Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman, Kajang 43000, Malaysia.

ORCID-Profile: Zenghao Bi, Suleixin Yang, Liang Leng

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • China National Postdoctoral Program for Innovative Talents
  • China Postdoctoral Science Foundation

Zitieren

APA

Qing, Y., Zhao, W., Xue, L., Luo, Y., Gao, Y., Sun, X., Li, F., Dai, L., Mo, J., Xu, G., Bi, Z., Yang, S., Hee, W. T., Li, J., & Leng, L. (2026). Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury. Cells. https://doi.org/10.3390/cells15030292

Vancouver

Qing Y, Zhao W, Xue L, Luo Y, Gao Y, Sun X, et al. Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury. Cells. 2026. doi:10.3390/cells15030292

BibTeX
@article{Qing2026,
  author = {Qing, Yifan and Zhao, Wenbo and Xue, Liangliang and Luo, Yu and Gao, Yuhao and Sun, Xiang and Li, Fan and Dai, Linxuan and Mo, Jing and Xu, Guoqing and Bi, Zenghao and Yang, Suleixin and Hee, Woo Tiam and Li, Jie and Leng, Liang},
  title = {Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15030292}
}
Kostenlos starten →